```html

Enteric (Typhoid) Fever – A Complete Medical Guide

Overview

Enteric fever, commonly known as typhoid fever, is a systemic bacterial infection caused primarily by Salmonella enterica serotype Typhi (S. Typhi). The disease spreads through ingestion of food or water contaminated with feces from an infected person. In rare cases, other Salmonella serotypes (e.g., Paratyphi A, B, or C) cause a similar “paratyphoid” illness.

Typhoid fever remains a major public‑health problem in low‑ and middle‑income countries, especially in parts of South Asia, Sub‑Saharan Africa, and Latin America. According to the World Health Organization (WHO), there are an estimated 11–20 million cases worldwide each year, resulting in 130,000–160,000 deaths (WHO, 2023).

The disease most often affects children aged 5–14 years and young adults, but anyone who consumes contaminated food or water can become infected. Travelers to endemic regions are also at heightened risk.

Symptoms

Symptoms usually appear 6–30 days after exposure (average ≈ 14 days). The illness progresses through three phases: rising, plateau, and convalescent.

Early (Rising) Phase – 1 week

• Gradual fever (often rising to > 38.5 °C/101.5 °F)
• Headache – dull, persistent
• Generalized weakness and malaise
• Loss of appetite (anorexia)
• Abdominal discomfort – vague, crampy pain
• Dry, “scratchy” throat
• Occasional cough or mild upper‑respiratory symptoms

Plateau Phase – Days 8–14

• High, sustained fever (often 38–40 °C/100‑104 °F)
• Rose‑colored spots (“rose spots”) on the trunk and abdomen (seen in 5‑10 % of patients)
• Abdominal distension and palpable enlarged liver (hepatomegaly) and sometimes spleen (splenomegaly)
• Diarrhea (in children) or constipation (in adults)
• Vomiting – may be occasional
• Splinter‑like hemorrhages on the skin (petechiae) or “white‑eyed” conjunctival hemorrhage

Convalescent Phase – After 2‑4 weeks

• Fever subsides gradually
• Fatigue, weakness, and weight loss may persist for weeks
• Hair loss (telogen effluvium) can occur after recovery

Because many of these signs overlap with other febrile illnesses (e.g., malaria, dengue, gastroenteritis), laboratory confirmation is essential.

Causes and Risk Factors

Primary Cause

Typhoid fever is caused by ingestion of S. Typhi bacteria, which survive stomach acid and proliferate in the small intestine. The organism penetrates the intestinal mucosa, enters the bloodstream, and spreads to the reticulo‑endothelial system (liver, spleen, bone marrow).

Key Risk Factors

• Living in or traveling to endemic areas where safe water and sanitation are lacking.
• Consumption of contaminated food or water – raw vegetables washed with unsafe water, street‑food salads, unpasteurized dairy.
• Close contact with a carrier (asymptomatic individuals who shed S. Typhi in stool).
• Age – children and adolescents have higher incidence.
• Immunocompromised status – HIV infection, malnutrition, or chronic diseases.
• Poor personal hygiene – inadequate hand‑washing after toileting.
• Travel during outbreaks – e.g., large gatherings in endemic regions.

Diagnosis

Because early symptoms are non‑specific, clinicians rely on a combination of clinical suspicion and laboratory testing.

Laboratory Tests

• Blood cultures – Gold standard; positivity 50‑80 % if drawn before antibiotics. Samples are usually taken from two separate sites.
• Stool and urine cultures – Useful after the first week or for identifying chronic carriers.
• Bone‑marrow culture – Highest sensitivity (≈ 90 %) but invasive; reserved for cases where blood cultures are negative and suspicion remains high.
• Serologic tests – Widal test (detects antibodies against O and H antigens) is widely used in resource‑limited settings but has poor specificity and is not recommended as a sole diagnostic tool (CDC, 2022).

Additional Tests

• Complete blood count (CBC): often shows mild leukopenia, anemia, and thrombocytopenia.
• Liver function tests: mild elevations in transaminases.
• Imaging (ultrasound or CT) if complications such as intestinal perforation or abscess are suspected.

Treatment Options

Effective therapy hinges on early diagnosis and appropriate antibiotic selection. Resistance patterns vary by region, so local susceptibility data guide therapy.

First‑Line Antibiotics (as of 2024)

• Ceftriaxone 2 g IV/IM once daily for 10‑14 days (recommended for areas with high fluoroquinolone resistance).
• Azithromycin 1 g PO on day 1, then 500 mg PO daily for 6 days (oral option, useful for less severe disease).

Alternative Regimens

• Fluoroquinolones (e.g., ciprofloxacin 500 mg PO BID) – still effective in regions where susceptibility is confirmed; however, resistance is rising.
• Carbapenems (e.g., meropenem) – reserved for multidrug‑resistant (MDR) or extensively drug‑resistant (XDR) strains.

Supportive Care

• Oral or IV rehydration to replace fluids lost through fever, diarrhea, or vomiting.
• Antipyretics (acetaminophen) for fever and headache; avoid NSAIDs if gastrointestinal bleeding is a concern.
• Nutritional support – high‑calorie, easily digestible diet.

Carrier Management

Individuals who remain stool‑positive for > 12 months despite treatment are considered chronic carriers. A regimen of high‑dose oral ciprofloxacin (or azithromycin) for 4 weeks, followed by repeat cultures, is recommended. Cholecystectomy (removal of the gallbladder) may be necessary if the carrier harbors bacteria in biliary stones.

Living with Enteric Fever (Typhoid Fever)

Even after completing antibiotics, patients may experience lingering fatigue and gastrointestinal upset. The following strategies help promote recovery and prevent relapse:

• Hydration – Aim for 2‑3 L of fluids daily (water, oral rehydration salts, clear broths).
• Balanced diet – Soft, low‑fat foods; gradually re‑introduce fiber as tolerance improves.
• Rest – Allow 10‑14 days of reduced activity; avoid strenuous exercise until energy returns.
• Medication adherence – Finish the full antibiotic course even if symptoms improve.
• Hand hygiene – Wash hands with soap and water after using the toilet and before handling food.
• Follow‑up testing – Repeat blood or stool cultures 1 week after therapy to confirm eradication, especially in high‑risk patients.

Prevention

Vaccination

• Vi polysaccharide vaccine (Typhim Vi) – Single intramuscular dose; provides ~ 55‑70 % protection for 2‑3 years.
• Live attenuated oral vaccine (Vivotif) – Four doses taken every other day; protection up to 5 years.
• Vaccination is recommended for travelers ≥ 6 months old visiting endemic areas, for residents of endemic regions, and for laboratory personnel handling S. Typhi.

Safe Food & Water Practices

• Drink only bottled, boiled, or filtered water; avoid ice made from untreated water.
• Eat foods that are thoroughly cooked and served hot; keep hot foods above 60 °C (140 °F).
• Peel fruits and vegetables yourself; wash them with safe water or use a disinfectant (e.g., chlorine solution).
• Avoid raw salads, uncooked sprouts, and street foods with unknown hygiene standards.

Sanitation & Hygiene

• Use latrines or flush toilets; if unavailable, practice “cat‑hole” latrine construction and cover waste promptly.
• Hand‑wash with soap for at least 20 seconds after defecation and before meals.
• Educate families and community leaders about transmission pathways.

Complications

When untreated or inadequately treated, typhoid fever can lead to serious, sometimes fatal, complications (occurring in ≈ 10‑15 % of patients).

• Intestinal hemorrhage – Erosion of the ileal mucosa causing massive bleeding.
• Intestinal perforation (most common 2‑3 weeks after onset) – Leads to peritonitis and sepsis; surgical emergency.
• Hepatomegaly & hepatic necrosis – May cause jaundice.
• Acute renal failure – Resulting from hypovolemia or septic shock.
• Encephalopathy – Confusion, delirium, or seizures (“typhoid encephalitis”).
• Endocarditis & osteomyelitis – Rare but documented in immunocompromised hosts.
• Chronic carrier state – Persistent bacterial shedding can perpetuate community transmission.

When to Seek Emergency Care

---

```